ATE82126T1 - Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck. - Google Patents

Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.

Info

Publication number
ATE82126T1
ATE82126T1 AT87902995T AT87902995T ATE82126T1 AT E82126 T1 ATE82126 T1 AT E82126T1 AT 87902995 T AT87902995 T AT 87902995T AT 87902995 T AT87902995 T AT 87902995T AT E82126 T1 ATE82126 T1 AT E82126T1
Authority
AT
Austria
Prior art keywords
capillary
cell
preparation
membrane leak
angiogenesis
Prior art date
Application number
AT87902995T
Other languages
English (en)
Inventor
Larrian Gillespie
Original Assignee
Angiogenics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/020,859 external-priority patent/US4820693A/en
Application filed by Angiogenics Ltd filed Critical Angiogenics Ltd
Application granted granted Critical
Publication of ATE82126T1 publication Critical patent/ATE82126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT87902995T 1986-04-04 1987-04-03 Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck. ATE82126T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84828886A 1986-04-04 1986-04-04
US86598186A 1986-05-22 1986-05-22
US07/020,859 US4820693A (en) 1986-05-22 1987-03-02 Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
EP87902995A EP0299975B1 (de) 1986-04-04 1987-04-03 Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck
PCT/US1987/000704 WO1987005808A1 (en) 1986-04-04 1987-04-03 Composition for arresting angiogenesis and capillary, cell or membrane leakage

Publications (1)

Publication Number Publication Date
ATE82126T1 true ATE82126T1 (de) 1992-11-15

Family

ID=27361529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87902995T ATE82126T1 (de) 1986-04-04 1987-04-03 Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.

Country Status (7)

Country Link
EP (1) EP0299975B1 (de)
AT (1) ATE82126T1 (de)
AU (1) AU600271B2 (de)
DE (1) DE3782652D1 (de)
DK (1) DK634987A (de)
NO (1) NO875025D0 (de)
WO (1) WO1987005808A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
EP0356435B1 (de) * 1987-03-19 1995-10-18 Arthropharm Pty. Limited Antientzündungsmittel und zusammensetzungen
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5021404A (en) * 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
AU678760B2 (en) * 1991-11-11 1997-06-12 Trustees Of The University Of Pennsylvania, The Methods of inhibiting restenosis
KR102472214B1 (ko) 2018-02-28 2022-11-30 삼성전자주식회사 에어 컨디셔닝 시스템에서 복합 제어 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3373782D1 (en) * 1982-12-20 1987-10-29 Harvard College Inhibition of angiogenesis

Also Published As

Publication number Publication date
EP0299975A4 (de) 1989-10-25
DK634987D0 (da) 1987-12-03
DK634987A (da) 1987-12-03
EP0299975A1 (de) 1989-01-25
WO1987005808A1 (en) 1987-10-08
EP0299975B1 (de) 1992-11-11
NO875025L (no) 1987-12-02
NO875025D0 (no) 1987-12-02
AU600271B2 (en) 1990-08-09
DE3782652D1 (de) 1992-12-17
AU7286287A (en) 1987-10-20

Similar Documents

Publication Publication Date Title
FR2588189B1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
NL190693C (nl) Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
DE69940674D1 (de) Orale verabreichung von adenosin analogen
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
EP0023359A3 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
NL169681C (nl) Anti-conceptisch combinatiepreparaat.
BE777689A (fr) Nouveaux derives de l'imidazoline, compositions therapeutiques les contenant ainsi que le procede de preparation de ces derives et de ces compositions
DK324687A (da) Transdermalt farmeceutisk praeparat
KR860000865A (ko) 약제 제형의 제조방법
IT1203791B (it) Derivati del morfinano e della morfina,loro preparazione,loro impiego come medicamenti e e le composizioni farmaceutiche che li contengono
DE3782652D1 (de) Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.
DK493386A (da) Benzimidazoler, -oxazoler og -thiazoler, deres anvendelse i farmaceutiske kompositioner og fremgangsmaade til forbindelsernes fremstilling
GB1390803A (en) Medicinal tampons and compositions containing lactulose
IT8424283A0 (it) Uso di derivati del tiofene nel trattamento dei tumori, composizioni farmaceutiche che licontengono e composti atti allo scopo.
DK69685A (da) Oralt praeparat, der indeholder allergen
SE7701263L (sv) Terapeutiska kompositioner och anvendning derav
SE8501312L (sv) Oral doseringsform for etopsid
JPH09124475A (ja) スルファサラジンを必須成分とする静脈不全および静脈潰瘍の治療用医薬組成物
ES449910A1 (es) Procedimiento para la obtencion de preparados antihelminti- cos.
RO92640B1 (ro) Metoda pentru tratamentul keratitelor virotice
IT8721098A0 (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
ES224152A1 (es) UN MÉTODO DE FORMAR UNA COMPOSICIoN FARMACÉUTICA LAXANTE PARA ADMINISTRACION POR VIA ORAL
IT1167538B (it) Derivati della dregamina, procedimento per la loro preparazione, composizioni farmaceutiche che li contengono e loro impiego terapeutico
KAJIKAWA Production and Market of Raw-Silk in 19th Century A Case Study of Fukumitsu, Toyama Prefecture

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties